Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT02071641 · TERMINATED
Trial details
- NCT number
- NCT02071641
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-09-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.